Catalysts for $ABBV
477 tracked
Dec 18, 2020
approval
IMBRUVICA (IBRUTINIB) — FDA approval
AbbVie Inc.
→
Dec 18, 2020
approval
IMBRUVICA (IBRUTINIB) — FDA approval
AbbVie Inc.
→
Dec 16, 2020
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Dec 16, 2020
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Nov 19, 2020
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Oct 21, 2020
approval
OZURDEX (DEXAMETHASONE) — FDA approval
dexamethasone LA
→
Oct 16, 2020
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Oct 16, 2020
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
Sep 22, 2020
approval
LINZESS (LINACLOTIDE) — FDA approval
linaclotide
→
Aug 7, 2020
approval
IMBRUVICA (IBRUTINIB) — FDA approval
AbbVie Inc.
→
Aug 7, 2020
approval
IMBRUVICA (IBRUTINIB) — FDA approval
AbbVie Inc.
→
Jul 10, 2020
approval
RINVOQ (UPADACITINIB) — FDA approval
upadacitinib tartrate ER
→
Jun 12, 2020
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
May 29, 2020
approval
ORIAHNN (COPACKAGED) (ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE) — FDA approval
ORIAHNN (COPACKAGED)
→
May 29, 2020
approval
VENCLEXTA (VENETOCLAX) — FDA approval
venetoclax
→
May 21, 2020
approval
DUOPA (CARBIDOPA) — FDA approval
carbidopa
→
May 19, 2020
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
May 19, 2020
approval
DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
May 19, 2020
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Apr 21, 2020
approval
IMBRUVICA (IBRUTINIB) — FDA approval
AbbVie Inc.
→
Apr 21, 2020
approval
IMBRUVICA (IBRUTINIB) — FDA approval
AbbVie Inc.
→
Mar 20, 2020
approval
SKYRIZI (RISANKIZUMAB-RZAA) — FDA approval
risankizumab
→
Mar 11, 2020
approval
HUMIRA (ADALIMUMAB) — FDA approval
adalimumab
→
Dec 5, 2019
approval
DUOPA (CARBIDOPA) — FDA approval
carbidopa
→
Nov 22, 2019
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Nov 22, 2019
approval
DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Nov 22, 2019
approval
DEPAKOTE (DIVALPROEX SODIUM) — FDA approval
divalproex sodium DR
→
Nov 21, 2019
approval
IMBRUVICA (IBRUTINIB) — FDA approval
AbbVie Inc.
→
Nov 21, 2019
approval
IMBRUVICA (IBRUTINIB) — FDA approval
AbbVie Inc.
→
Aug 28, 2019
approval
ORILISSA (ELAGOLIX SODIUM) — FDA approval
elagolix sodium
→